ALS News Today Home | ALS News Today
WEB3 days ago · Targeting 3 cell types at same time seen to extend survival in ALS mice. A strategy that simultaneously targets motor neurons, astrocytes, and microglia — three cell types involved in the development and progression of amyotrophic lateral sclerosis (ALS) — was shown to further extend survival in a mouse model of the disease.
FDA Approves First ALS Treatment Via Accelerated Approval
WEBApr 25, 2023 · ALS Association Funded Antisense Technology Behind Tofersen. Washington, D.C. (April 25. 2023) – The ALS Association commends the FDA for approving tofersen under the agency’s accelerated approval pathway for the treatment of people living with ALS connected to mutations in the SOD1 gene.
A “Game-Changer” – Groundbreaking Discovery Paves Way for ALS …
WEBMay 29, 2024 · In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis (ALS).
Amyotrophic Lateral Sclerosis News -- ScienceDaily
WEBMar 13, 2024 · Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
Scientists may have discovered a potential cure for ALS - The Toronto Star
WEBMay 17, 2024 · A team of researchers at Western University have made a major breakthrough that could pave the way to a cure for amyotrophic lateral sclerosis (ALS) — a devastating nervous system disease that...
FDA final approval decision on NurOwn for ALS due by year’s end
WEBJun 8, 2023 · A final decision by the U.S. Food and Drug Administration (FDA) on whether or not to approve NurOwn for amyotrophic lateral sclerosis (ALS) is now expected no later than Dec. 8.
Phase 1 clinical trial of experimental ALS therapy ... - ALS News …
WEBAug 28, 2023 · Akava Therapeutics will soon launch a Phase 1 clinical trial to test AKV9, its investigational therapy for amyotrophic lateral sclerosis (ALS), in healthy people. The trial follows the clearance of Akava’s investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA).
Epigenomic analysis sheds light on risk factors for ALS
WEBMay 2, 2024 · In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.
In reversal, FDA panel votes to recommend experimental ALS drug - NBC News
WEBSep 7, 2022 · A Food and Drug Administration advisory panel voted Wednesday to recommend an experimental drug for patients with ALS, a reversal from its decision in March and a victory for advocacy groups ...
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis
WEB4 days ago · This paper from Brain Chemistry Labs aims to propose a new blood test for amyotrophic lateral sclerosis (ALS). It discusses the challenges of diagnosing ALS and the need for better biomarkers. The authors propose an eight-microRNA signature test using extracellular vesicles in blood plasma. They found this test to be accurate in identifying ALS ...